Ann: Agreement for anticipated Aspiral China sales approx USD45M, page-53

Congrats long termers. This was the announcement that we were waiting over. I think we can safely say that the demo phase is over, and we are moving into early commercial development.

The more units installed out there, the more data generated and monitoring of performance. In turn leading to higher levels of confidence of potential customers to adopt MABR. Unfortunately, it is a tedious process. But once accepted, it's hard to knock them over. Only the beginning of the beginning. Congrats to all having come this far.

@Dungiven, will join you in that glass of wine. Cheers.